Lot/serial number was manufactured prior to udi compliance date; therefore, only a di is provided evaluation of the customer issue included a review of the complaint text, a search for similar complaints, a batch record review, and a labeling review.No adverse trend was identified for the customer issue.Labeling was reviewed and found to be adequate.Batch record review did not identify any issues that may have caused the customer issue.Based on all available information and abbott diagnostics complaint investigation, no product deficiency was identified.(b)(6).
|
The customer observed elevated bilirubin results while using the clinical chemistry total bilirubin reagents.The following data, generated on (b)(6) 2016, was provided for the same patient (umol/l).The patient was a (b)(6) baby.Sid (b)(6) (replicate id (b)(6)) initial 374.9.Sid (b)(6) (replicate id (b)(6)) retest (1:30 hours later) 180.0.Sid (b)(6) (replicate id (b)(6) ) retest 179.8.No impact to patient management was reported.
|